Pio-LN Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Side Effects Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Pioglitazone HCl

Indications/Uses

Combination therapy of type 2 diabetes in patients w/ poor glycemic control on metformin monotherapy or sulfonylurea.

Click to view Pio-LN detailed prescribing information

Dosage/Direction for Use

Adult Monotherapy: 15 or 30 mg as starting dose once daily. Combination w/ metformin or sulfonylurea: 15 or 30 mg/day.

Click to view Pio-LN detailed prescribing information

Overdosage

View Pio-LN overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity. Patient w/ or history of heart failure. Liver function abnormalities: Contraindicated w/ insulin.

Click to view Pio-LN detailed prescribing information

Special Precautions

Not for monotherapy. Not recommended for use in dialysis patients, hepatic impairment. Monitor for signs & symptoms of heart failure. Discontinue in case of cardiac dysfunction, jaundice. Co-administration w/ NSAIDs may increase the risk of edema. Perform LFTs before therapy & monitor periodically thereafter. Do not administer in patient w/ elevated levels of liver enzymes (ALT >2.5 x ULN) or presence of liver disease. Not to be used in pregnancy & breastfeeding women. Not recommended in childn <18 yr.

Click to view Pio-LN detailed prescribing information

Adverse Reactions

Combination w/ metformin: Anemia, wt gain, headache, visual disturbances, arthralgia, haematuria, impotence. Combination w/ sulfonylurea: Wt gain, glycosuria, hypoglycaemia, increased lactose dehydrogenase, increased appetite, dizziness, headache, vertigo, visual disturbances, sweating, proteinuria, fatigue.

Storage

View Pio-LN storage conditions for details to ensure optimal shelf-life.

Description

View Pio-LN description for details of the chemical structure and excipients (inactive components).

Action

View Pio-LN mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antidiabetic Agents

ATC Classification

A10BG03 - pioglitazone ; Belongs to the class of thiazolidinediones. Used in the treatment of diabetes.

Regulatory Classification

Presentation/Packing

Form

Pio-LN tab 15 mg

Packing/Price

3 × 10's

Form

Pio-LN tab 30 mg

Packing/Price

3 × 10's

Pio-LN

pioglitazone

Manufacturer:

Landson